SMAD2 and pancreatic neoplasm: Further investigation of the effect of SMAD2/3 activation on PNI in pancreatic cancer revealed that activating SMAD2/3 signaling increased the cancer cell invasion index and the DRG axon growth index (Figures 3I, J).